July 9, 2018 12:51 pm
Published by jonas
Redwood Pharma has submitted its first national clinical trial application for the start of the RP101 trial. This application represents... View Article
June 13, 2018 11:26 am
Published by jonas
CEO Martin Vidaeus presented (ENG) at the investor forum Småbolagsdagen held at the Sheraton Hotel in Stockholm, Sweden by the... View Article
May 30, 2018 5:03 pm
Published by jonas
Redwood Pharma will be presenting at Nordic Life Science Days in Stockholm, Sep. 10-12. The Company will also meet and... View Article
April 26, 2018 9:23 am
Published by jonas
The Board of Directors of Redwood Pharma AB (publ) (“Redwood” or the “Company”) today makes public the outcome of the... View Article
March 15, 2018 7:24 pm
Published by jonas
Press release 03-15-2018 On March 15, 2018, Redwood Pharma AB (publ)’s Board of Directors decided to execute a new rights... View Article
March 8, 2018 7:00 pm
Published by jonas
Redwood Pharma has entered into an agreement regarding the acquisition of certain patent and patent applications, as well as clinical... View Article
February 26, 2018 1:30 pm
Published by jonas
Redwood Pharma has signed a Materials Transfer Agreement where an Asian pharmaceutical firm will obtain IntelliGel® for the purposes of... View Article
February 26, 2018 8:30 am
Published by jonas
Redwood Pharma has met with the Swedish Medical Products Agency in an advisory discussion. The meeting gave the company the... View Article
February 23, 2018 12:00 pm
Published by jonas
The United States Patent and Trade Mark Office (USPTO) has communicated its intention to grant a new US patent in... View Article
January 22, 2018 12:00 pm
Published by jonas
Redwood Pharma will be attending BIO-Europe 2018 in Amsterdam, Mar. 11 – 14 to meet and continue discussions with potential... View Article